Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-22

FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)

View source ↗

Summary

FDA approves Glenmark's diltiazem hydrochloride as an original ANDA; the product is a generic calcium channel blocker indicated for hypertension and certain ang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

ORIG AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)